Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohortSigbjørn Smeland, Beate Timmermann, Pancras C.W. Hogendoorn et al.|European Journal of Cancer|2019Cited by 724
Chemotherapeutic adjuvant treatment for osteosarcoma: Where do we stand?Jakob Anninga, R. Maarten Egeler, Hans Gelderblom et al.|European Journal of Cancer|2011Cited by 464